At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immunological disorders. Our goal is to provide patients and caregivers with more efficacious therapies that significantly reduce treatment burden. Our vision is embodied in our current focus – the development of a groundbreaking anti-TSLP therapy with best-in-class potential.

We are a San Francisco Bay area-based clinical stage biopharma company with additional operations in London, UK. The Aiolos team is comprised of seasoned drug developers, who have successfully developed and launched products for a range of immune conditions, including asthma, rheumatoid arthritis, IPF, and more. As we grow, we will look to add like-minded individuals to our team - those committed to the goal of providing a meaningful difference in the lives of patients suffering from respiratory illnesses and other immune disorders.

Biotechnology

Life Sciences

Pharmaceutical

Aiolos Bio

Khurem Farooq

Ivie Butcher

Mandi Conklin

Sara Harmon

Michael Gladstone

Amir Zamani

Tapan Maniar

Sosei Heptares

Jane Hughes

Ashley Taylor

The Clinical Operations team at Aiolos Bio is responsible for overseeing and executing clinical trials to advance our groundbreaking anti-TSLP therapy. This team manages the planning, coordination, and implementation of clinical research activities, ensuring regulatory compliance and operational efficiency. By working closely with research sites and strategic partners globally, they aim to deliver high-quality data that supports the development of innovative treatments for respiratory diseases and other immunological disorders.

Clinical Operations

Leadership Team

Clinical Operations

About

Team members

Other teams at Aiolos Bio

Leadership Team